7MY2

CryoEM structure of neutralizing nanobody Nb30 in complex with SARS-CoV2 spike

7MY2 の概要

• エントリーDOI: 10.2210/pdb7my2/pdb
• EMDBエントリー: 24077
• 分子名称: Spike glycoprotein, Nanobody Nb30, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (6 entities in total)
• 機能のキーワード: sars-cov2, nanobody, neutralizing, spike, immune system-viral protein complex, immune system/viral protein
• 由来する生物種: Severe acute respiratory syndrome coronavirus 2 (2019-nCoV, SARS-CoV-2, COVID-19 virus); 詳細
• タンパク質・核酸の鎖数: 6
• 化学式量合計: 483727.47

構造登録者

Xu, K.,Kwong, P.D. (登録日: 2021-05-20, 公開日: 2021-06-16, 最終更新日: 2021-07-28)

• 主引用文献: Xu, J.,Xu, K.,Jung, S.,Conte, A.,Lieberman, J.,Muecksch, F.,Lorenzi, J.C.C.,Park, S.,Schmidt, F.,Wang, Z.,Huang, Y.,Luo, Y.,Nair, M.S.,Wang, P.,Schulz, J.E.,Tessarollo, L.,Bylund, T.,Chuang, G.Y.,Olia, A.S.,Stephens, T.,Teng, I.T.,Tsybovsky, Y.,Zhou, T.,Munster, V.,Ho, D.D.,Hatziioannou, T.,Bieniasz, P.D.,Nussenzweig, M.C.,Kwong, P.D.,Casellas, R.; Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants.; Nature, 595:278-282, 2021; PubMed: 34098567; DOI: 10.1038/s41586-021-03676-z

実験手法

ELECTRON MICROSCOPY (2.65 Å)